The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

P. Jain, H. Kantarjian, F. Ravandi, D. Thomas, S. O'Brien, T. Kadia, J. Burger, G. Borthakur, N. Daver, E. Jabbour, M. Konopleva, J. Cortes, N. Pemmaraju, M. A. Kelly, M. Cardenas-Turanzas, R. Garris, S. Faderl

Research output: Contribution to journal › Letter › peer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience'. Together they form a unique fingerprint.